Given
the various viral outbreaks in the 21st century, specifically
the present pandemic situation arising from SARS-CoV-2 or the coronavirus,
of unknown magnitude, there is an unmet clinical need to develop effective
therapeutic and diagnostic strategies to combat this infectious disease
worldwide. To develop precise anticoronavirus drugs and prophylactics,
tissue engineering and biomaterial research strategies can serve as
a suitable alternative to the conventional treatment options. Therefore,
in this Review, we have highlighted various tissue engineering-based
diagnostic systems for SARS-CoV-2 and suggested how these strategies
involving organ-on-a-chip, organoids, 3D bioprinting, and advanced
bioreactor models can be employed to develop in vitro human tissue models, for more efficient diagnosis, drug/vaccine
development, and focusing on the need for patient-specific therapy.
We believe that combining the basics of virology with tissue engineering
techniques can help the researchers to understand the molecular mechanism
underlying viral infection, which is critical for effective drug design.
In addition, it can also serve to be a suitable platform for drug
testing and delivery of small molecules that can lead to therapeutic
tools in this dreaded pandemic situation. Additionally, we have also
discussed the essential biomaterial properties which polarize the
immune system, including dendritic cells and macrophages, toward their
inflammatory phenotype, which can thus serve as a reference for exhibiting
the role of biomaterial in influencing the adaptive immune response
involving B and T lymphocytes to foster a regenerative tissue microenvironment.
The situation arising from SARS-CoV-2 poses a challenge to scientists
from almost all disciplines, and we feel that tissue engineers can
thus provide new translational opportunities in this dreadful pandemic
situation.